サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1179650

アダプトゲン市場：供給源別、最終用途別、用途別、流通チャネル別：世界の機会分析および産業予測、2021-2031年

Adaptogens Market By Source, By End Use, By Application, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 320 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
アダプトゲン市場：供給源別、最終用途別、用途別、流通チャネル別：世界の機会分析および産業予測、2021-2031年
出版日: 2022年09月01日
発行: Allied Market Research
ページ情報: 英文 320 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アダプトゲンの市場規模は2021年に103億2,020万米ドル、2022年から2031年にかけてCAGR7.3%を記録し、2031年には203億2,860万米ドルに達すると予測されています。

アダプトゲンは、体が自然な代謝を調整し、バランスを達成するのに役立つハーブを提供することを意味します。精神的なストレスの低下に役立ちます。アダプトゲン植物は厳しい気候の中で発見され、例えばアシュワガンダは砂漠で育つ。アシュワガンダやホーリーバジルなどの成分は、アシュワガンダの睡眠を改善する能力など、様々な健康上の利点と関連付けられています。高麗人参、Rohdiola、Schisandraは、体内の急性ストレスの引き金に対処するのに有効です。高麗人参は、身体の免疫システムを改善するために使用されます。すべてのアダプトゲンの中で、アシュワガンダはその健康上の利点により、大きな市場シェアを占めています。

Adaptogensは、このようなアダプトゲンお茶や食品と＆カプセルの形で消費することができるアダプトゲンから成るプレミックスパウダーなど、多くの形態で利用可能です。これらのすべての形態のうち、アダプトゲンのプレミックスパウダーは、食品だけでなく、水などの液体で混合することによって消費されるように、その能力のために主要な市場シェアを持っています。

アダプトゲン市場の成長を促進する主な要因は、世界中の消費者の間でストレスの量の増加です。ストレスのアメリカ研究所の研究では、それは約73％の人々がストレスのために睡眠に問題がある人々の48％として彼らの精神的健康に影響を与える、ストレスを持っていることが設立されました。

また、ストレスの世界の組織の報告によると、近年、75％近くの人が中程度から高いレベルのストレスを経験しているとされています。そして、このようなストレスを治すために、アダプトゲンはその新しい医薬品ソリューションになる可能性があります。また、飲料業界と健康食品の消費者からアダプトゲンの需要の増加は、アダプトゲンは不安を軽減し、精神的安定性を高めるのに役立ち、粉末状で提供されているとして、アプリケーションに基づいて、アダプトゲン市場は、食品＆飲料、栄養＆スポーツサプリメント、化粧品、動物飼料、医薬品に区分されています。すべてのセグメントのうち、食品と飲料は、食事やサプリメントとしてお茶などの飲料の形でアダプトゲンの使用量のため、最大の市場シェアを保持しています。

アジア太平洋地域は、世界のアダプトゲン市場のための大きなシェアを持っています。この成長は、アダプトゲンが広くインドで実践されているアーユルヴェーダで使用され、最終的にインドの大幅な市場成長につながるという事実に起因しています。韓国や中国などの他のアジア諸国は、伝統医学におけるアダプトゲンの最大のユーザーの一つです。また、新興国からの需要と飲食品や栄養補助食品＆スポーツサプリメントでアダプトゲンの使用量の増加は、今後アダプトゲン市場のメーカーのための新たな機会を作成しようとしています。しかし、研究開発活動のコストの上昇は抑制要因として主要な要因として作用し、今後、アダプトゲン市場のためのさらなる課題となることが期待されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 アダプトゲン市場：供給元別

  • 概要
    • 市場規模および予測
  • アシュワガンダ
    • 主な市場動向、成長要因と機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 高麗人参
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • ハトムギ
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • ホーリーバジル
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • ロディオラロゼアス
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • シザンドラ
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • アダプトジェニックマッシュルーム
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第5章 アダプトゲン市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • 粉体
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • カプセル
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • お茶・飲料
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • その他
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第6章 アダプトゲン市場：用途別

  • 概要
    • 市場規模および予測
  • 飲食品分野
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 栄養補助食品、スポーツサプリメント
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 化粧品
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 動物飼料
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 医薬品
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第7章 アダプトゲン市場： 流通チャネル別

  • 概要
    • 市場規模・予測
  • B2B
    • 主な市場動向、成長要因と機会
    • 市場規模・予測：地域別
    • 市場分析：国別分析
  • B2C
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
    • B2Cアダプトゲン市場：販売チャネル別
      • スーパーマーケット、ハイパーマーケット市場規模・予測：地域別
      • 専門店市場規模推移・予測：地域別
      • 薬局・薬店市場規模・予測：地域別
      • その他市場規模・予測：地域別

第8章 アダプトゲン市場：地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主要動向と機会
    • 北米の市場規模・予測：供給元別
    • 北米市場規模・予測：エンドユーザー別
    • 北米市場規模・予測：用途別
    • 北米の市場規模・予測：流通チャネル別
      • 北米のB2Cアダプトゲン市場：販売チャネル別
    • 北米の市場規模・予測：国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州市場規模・予測：ソース別
    • 欧州の市場規模・予測：エンドユーザー別
    • 欧州市場規模・予測：アプリケーション別
    • 欧州市場規模・予測：流通チャネル別
      • 欧州B2Cアダプトゲン市場：販売チャネル別
    • 欧州市場規模・予測：国別
      • 英国
      • イタリア
      • ドイツ
      • フランス
      • スペイン
      • オランダ
      • スイス
      • その他欧州
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測：供給元別
    • アジア太平洋地域の市場規模・予測：エンドユーザー別
    • アジア太平洋地域の市場規模・予測：アプリケーション別
    • アジア太平洋地域の市場規模・予測：流通チャネル別
      • アジア太平洋地域のB2Cアダプトゲン市場：販売チャネル別
    • アジア太平洋地域の市場規模・予測：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • オーストラリア
      • インドネシア
      • タイ
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測：供給元別
    • LAMEAの市場規模・予測：エンドユーザー別
    • LAMEAの市場規模・予測：アプリケーション別
    • LAMEAの市場規模・予測：流通チャネル別
      • LAMEAのB2Cアダプトゲン市場：販売チャネル別
    • LAMEAの市場規模・予測：国別
      • ラテンアメリカ
      • 中東
      • アフリカ

第9章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第10章 企業プロファイル

  • Dabur India Ltd
  • Emami Limited
  • kairali ayurvedic group
  • Himalaya Wellness
  • Colgate-Palmolive Company
  • Procter & Gamble
  • Patanjali Ayurved Limited
  • Shahnaz Ayurveda Pvt. Ltd.
  • Shree Baidyanath Ayurveda Bhawan Pvt. Ltd
  • Unilever
  • ENOMARK BIOTECH（ENOMARK HEALTHCARE）
  • Riaan Wellness Pvt. Ltd.
  • .Givaudan International SA（NATUREX S.A.）
  • PLT Health Solutions
  • INDENA S.P.A
図表

LIST OF TABLES

  • TABLE 1. GLOBAL ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 2. ADAPTOGENS MARKET, FOR ASHWAGANDHA, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. ADAPTOGENS MARKET FOR ASHWAGANDHA, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. ADAPTOGENS MARKET, FOR GINSENG, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. ADAPTOGENS MARKET FOR GINSENG, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. ADAPTOGENS MARKET, FOR ASTRAGALUS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. ADAPTOGENS MARKET FOR ASTRAGALUS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. ADAPTOGENS MARKET, FOR  HOLY BASILS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. ADAPTOGENS MARKET FOR  HOLY BASILS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. ADAPTOGENS MARKET, FOR  RHODIOLA ROSEAS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. ADAPTOGENS MARKET FOR  RHODIOLA ROSEAS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 12. ADAPTOGENS MARKET, FOR SCHISANDRA, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. ADAPTOGENS MARKET FOR SCHISANDRA, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. ADAPTOGENS MARKET, FOR ADAPTOGENIC MUSHROOMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. ADAPTOGENS MARKET FOR ADAPTOGENIC MUSHROOMS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. ADAPTOGENS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. ADAPTOGENS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 18. GLOBAL ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 19. ADAPTOGENS MARKET, FOR POWDER, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. ADAPTOGENS MARKET FOR POWDER, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. ADAPTOGENS MARKET, FOR CAPSULES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. ADAPTOGENS MARKET FOR CAPSULES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. ADAPTOGENS MARKET, FOR TEAS AND BEVERAGES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. ADAPTOGENS MARKET FOR TEAS AND BEVERAGES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. ADAPTOGENS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. ADAPTOGENS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. GLOBAL ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 28. ADAPTOGENS MARKET, FOR  FOOD AND BEVERAGES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 29. ADAPTOGENS MARKET FOR  FOOD AND BEVERAGES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 30. ADAPTOGENS MARKET, FOR  DIETARY AND SPORTS SUPPLEMENTS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 31. ADAPTOGENS MARKET FOR  DIETARY AND SPORTS SUPPLEMENTS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 32. ADAPTOGENS MARKET, FOR COSMETICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 33. ADAPTOGENS MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 34. ADAPTOGENS MARKET, FOR  ANIMAL FEED, BY REGION, 2021-2031 ($MILLION)
  • TABLE 35. ADAPTOGENS MARKET FOR  ANIMAL FEED, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 36. ADAPTOGENS MARKET, FOR PHARMACEUTICAL, BY REGION, 2021-2031 ($MILLION)
  • TABLE 37. ADAPTOGENS MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 38. GLOBAL ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 39. ADAPTOGENS MARKET, FOR BUSINESS TO BUSINESS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 40. ADAPTOGENS MARKET FOR BUSINESS TO BUSINESS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 41. ADAPTOGENS MARKET, FOR BUSINESS TO CONSUMER, BY REGION, 2021-2031 ($MILLION)
  • TABLE 42. ADAPTOGENS MARKET FOR BUSINESS TO CONSUMER, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 43. GLOBAL BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
  • TABLE 44. ADAPTOGENS MARKET, FOR SUPERMARKET AND HYPERMARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 45. ADAPTOGENS MARKET, FOR SPECIALTY STORE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 46. ADAPTOGENS MARKET, FOR PHARMACIES AND DRUG STORES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 47. ADAPTOGENS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 48. ADAPTOGENS MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 49. NORTH AMERICA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 50. NORTH AMERICA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 51. NORTH AMERICA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 52. NORTH AMERICA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 53. NORTH AMERICA BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
  • TABLE 54. NORTH AMERICA ADAPTOGENS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 55. U.S. ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 56. U.S. ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 57. U.S. ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 58. U.S. ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 59. CANADA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 60. CANADA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 61. CANADA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 62. CANADA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 63. MEXICO ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 64. MEXICO ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 65. MEXICO ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 66. MEXICO ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 67. EUROPE ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 68. EUROPE ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 69. EUROPE ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 70. EUROPE ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 71. EUROPE BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
  • TABLE 72. EUROPE ADAPTOGENS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 73. UK ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 74. UK ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 75. UK ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. UK ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 77. ITALY ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 78. ITALY ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 79. ITALY ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 80. ITALY ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 81. GERMANY ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 82. GERMANY ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 83. GERMANY ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 84. GERMANY ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 85. FRANCE ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 86. FRANCE ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 87. FRANCE ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 88. FRANCE ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 89. SPAIN ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 90. SPAIN ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 91. SPAIN ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 92. SPAIN ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 93. THE NETHERLANDS ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 94. THE NETHERLANDS ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 95. THE NETHERLANDS ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 96. THE NETHERLANDS ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 97. SWITZERLAND ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 98. SWITZERLAND ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 99. SWITZERLAND ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 100. SWITZERLAND ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 101. REST OF EUROPE ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 102. REST OF EUROPE ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 103. REST OF EUROPE ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 104. REST OF EUROPE ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 105. ASIA-PACIFIC ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 106. ASIA-PACIFIC ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 107. ASIA-PACIFIC ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 108. ASIA-PACIFIC ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 109. ASIA-PACIFIC BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
  • TABLE 110. ASIA-PACIFIC ADAPTOGENS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 111. CHINA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 112. CHINA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 113. CHINA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 114. CHINA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 115. JAPAN ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 116. JAPAN ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 117. JAPAN ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 118. JAPAN ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 119. INDIA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 120. INDIA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 121. INDIA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 122. INDIA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 123. SOUTH KOREA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 124. SOUTH KOREA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 125. SOUTH KOREA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 126. SOUTH KOREA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 127. AUSTRALIA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 128. AUSTRALIA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 129. AUSTRALIA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 130. AUSTRALIA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 131. INDONESIA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 132. INDONESIA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 133. INDONESIA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 134. INDONESIA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 135. THAILAND  ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 136. THAILAND  ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 137. THAILAND  ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 138. THAILAND  ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 139. REST OF ASIA-PACIFIC ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 140. REST OF ASIA-PACIFIC ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 141. REST OF ASIA-PACIFIC ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 142. REST OF ASIA-PACIFIC ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 143. LAMEA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 144. LAMEA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 145. LAMEA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 146. LAMEA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 147. LAMEA BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
  • TABLE 148. LAMEA ADAPTOGENS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 149. LATIN AMERICA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 150. LATIN AMERICA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 151. LATIN AMERICA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 152. LATIN AMERICA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 153. MIDDLE EAST ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 154. MIDDLE EAST ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 155. MIDDLE EAST ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 156. MIDDLE EAST ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 157. AFRICA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 158. AFRICA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 159. AFRICA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 160. AFRICA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 161.DABUR INDIA LTD: COMPANY SNAPSHOT
  • TABLE 162.DABUR INDIA LTD: OPERATING SEGMENTS
  • TABLE 163.DABUR INDIA LTD: PRODUCT PORTFOLIO
  • TABLE 164.DABUR INDIA LTD: NET SALES,
  • TABLE 165.DABUR INDIA LTD: KEY STRATERGIES
  • TABLE 166.EMAMI LIMITED: COMPANY SNAPSHOT
  • TABLE 167.EMAMI LIMITED: OPERATING SEGMENTS
  • TABLE 168.EMAMI LIMITED: PRODUCT PORTFOLIO
  • TABLE 169.EMAMI LIMITED: NET SALES,
  • TABLE 170.EMAMI LIMITED: KEY STRATERGIES
  • TABLE 171.KAIRALI AYURVEDIC GROUP: COMPANY SNAPSHOT
  • TABLE 172.KAIRALI AYURVEDIC GROUP: OPERATING SEGMENTS
  • TABLE 173.KAIRALI AYURVEDIC GROUP: PRODUCT PORTFOLIO
  • TABLE 174.KAIRALI AYURVEDIC GROUP: NET SALES,
  • TABLE 175.KAIRALI AYURVEDIC GROUP: KEY STRATERGIES
  • TABLE 176.HIMALAYA WELLNESS: COMPANY SNAPSHOT
  • TABLE 177.HIMALAYA WELLNESS: OPERATING SEGMENTS
  • TABLE 178.HIMALAYA WELLNESS: PRODUCT PORTFOLIO
  • TABLE 179.HIMALAYA WELLNESS: NET SALES,
  • TABLE 180.HIMALAYA WELLNESS: KEY STRATERGIES
  • TABLE 181.COLGATE-PALMOLIVE COMPANY: COMPANY SNAPSHOT
  • TABLE 182.COLGATE-PALMOLIVE COMPANY: OPERATING SEGMENTS
  • TABLE 183.COLGATE-PALMOLIVE COMPANY: PRODUCT PORTFOLIO
  • TABLE 184.COLGATE-PALMOLIVE COMPANY: NET SALES,
  • TABLE 185.COLGATE-PALMOLIVE COMPANY: KEY STRATERGIES
  • TABLE 186.PROCTER & GAMBLE: COMPANY SNAPSHOT
  • TABLE 187.PROCTER & GAMBLE: OPERATING SEGMENTS
  • TABLE 188.PROCTER & GAMBLE: PRODUCT PORTFOLIO
  • TABLE 189.PROCTER & GAMBLE: NET SALES,
  • TABLE 190.PROCTER & GAMBLE: KEY STRATERGIES
  • TABLE 191.PATANJALI AYURVED LIMITED: COMPANY SNAPSHOT
  • TABLE 192.PATANJALI AYURVED LIMITED: OPERATING SEGMENTS
  • TABLE 193.PATANJALI AYURVED LIMITED: PRODUCT PORTFOLIO
  • TABLE 194.PATANJALI AYURVED LIMITED: NET SALES,
  • TABLE 195.PATANJALI AYURVED LIMITED: KEY STRATERGIES
  • TABLE 196.SHAHNAZ AYURVEDA PVT. LTD.: COMPANY SNAPSHOT
  • TABLE 197.SHAHNAZ AYURVEDA PVT. LTD.: OPERATING SEGMENTS
  • TABLE 198.SHAHNAZ AYURVEDA PVT. LTD.: PRODUCT PORTFOLIO
  • TABLE 199.SHAHNAZ AYURVEDA PVT. LTD.: NET SALES,
  • TABLE 200.SHAHNAZ AYURVEDA PVT. LTD.: KEY STRATERGIES
  • TABLE 201.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD: COMPANY SNAPSHOT
  • TABLE 202.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD: OPERATING SEGMENTS
  • TABLE 203.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD: PRODUCT PORTFOLIO
  • TABLE 204.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD: NET SALES,
  • TABLE 205.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD: KEY STRATERGIES
  • TABLE 206.UNILEVER: COMPANY SNAPSHOT
  • TABLE 207.UNILEVER: OPERATING SEGMENTS
  • TABLE 208.UNILEVER: PRODUCT PORTFOLIO
  • TABLE 209.UNILEVER: NET SALES,
  • TABLE 210.UNILEVER: KEY STRATERGIES
  • TABLE 211.ENOMARK BIOTECH (ENOMARK HEALTHCARE): COMPANY SNAPSHOT
  • TABLE 212.ENOMARK BIOTECH (ENOMARK HEALTHCARE): OPERATING SEGMENTS
  • TABLE 213.ENOMARK BIOTECH (ENOMARK HEALTHCARE): PRODUCT PORTFOLIO
  • TABLE 214.ENOMARK BIOTECH (ENOMARK HEALTHCARE): NET SALES,
  • TABLE 215.ENOMARK BIOTECH (ENOMARK HEALTHCARE): KEY STRATERGIES
  • TABLE 216.RIAAN WELLNESS PVT. LTD.: COMPANY SNAPSHOT
  • TABLE 217.RIAAN WELLNESS PVT. LTD.: OPERATING SEGMENTS
  • TABLE 218.RIAAN WELLNESS PVT. LTD.: PRODUCT PORTFOLIO
  • TABLE 219.RIAAN WELLNESS PVT. LTD.: NET SALES,
  • TABLE 220.RIAAN WELLNESS PVT. LTD.: KEY STRATERGIES
  • TABLE 221..GIVAUDAN INTERNATIONAL SA (NATUREX S.A.): COMPANY SNAPSHOT
  • TABLE 222..GIVAUDAN INTERNATIONAL SA (NATUREX S.A.): OPERATING SEGMENTS
  • TABLE 223..GIVAUDAN INTERNATIONAL SA (NATUREX S.A.): PRODUCT PORTFOLIO
  • TABLE 224..GIVAUDAN INTERNATIONAL SA (NATUREX S.A.): NET SALES,
  • TABLE 225..GIVAUDAN INTERNATIONAL SA (NATUREX S.A.): KEY STRATERGIES
  • TABLE 226.PLT HEALTH SOLUTIONS: COMPANY SNAPSHOT
  • TABLE 227.PLT HEALTH SOLUTIONS: OPERATING SEGMENTS
  • TABLE 228.PLT HEALTH SOLUTIONS: PRODUCT PORTFOLIO
  • TABLE 229.PLT HEALTH SOLUTIONS: NET SALES,
  • TABLE 230.PLT HEALTH SOLUTIONS: KEY STRATERGIES
  • TABLE 231.INDENA S.P.A: COMPANY SNAPSHOT
  • TABLE 232.INDENA S.P.A: OPERATING SEGMENTS
  • TABLE 233.INDENA S.P.A: PRODUCT PORTFOLIO
  • TABLE 234.INDENA S.P.A: NET SALES,
  • TABLE 235.INDENA S.P.A: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.ADAPTOGENS MARKET SEGMENTATION
  • FIGURE 2.ADAPTOGENS MARKET,2021-2031
  • FIGURE 3.ADAPTOGENS MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.ADAPTOGENS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.ADAPTOGENS MARKET,BY SOURCE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ASHWAGANDHA ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF GINSENG ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF ASTRAGALUS ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF  HOLY BASILS ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF  RHODIOLA ROSEAS ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SCHISANDRA ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ADAPTOGENIC MUSHROOMS ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 21.ADAPTOGENS MARKET,BY END USE,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF POWDER ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CAPSULES ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF TEAS AND BEVERAGES ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 26.ADAPTOGENS MARKET,BY APPLICATION,2021(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF  FOOD AND BEVERAGES ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF  DIETARY AND SPORTS SUPPLEMENTS ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF COSMETICS ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 30.COMPARATIVE SHARE ANALYSIS OF  ANIMAL FEED ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 31.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 32.ADAPTOGENS MARKET,BY DISTRIBUTION CHANNEL,2021(%)
  • FIGURE 33.COMPARATIVE SHARE ANALYSIS OF BUSINESS TO BUSINESS ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 34.COMPARATIVE SHARE ANALYSIS OF BUSINESS TO CONSUMER ADAPTOGENS MARKET,2021-2031(%)
  • FIGURE 35.ADAPTOGENS MARKET BY REGION,2021
  • FIGURE 36.U.S. ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 37.CANADA ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 38.MEXICO ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 39.UK ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 40.ITALY ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 41.GERMANY ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 42.FRANCE ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 43.SPAIN ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 44.THE NETHERLANDS ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 45.SWITZERLAND ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 46.REST OF EUROPE ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 47.CHINA ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 48.JAPAN ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 49.INDIA ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 50.SOUTH KOREA ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 51.AUSTRALIA ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 52.INDONESIA ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 53.THAILAND  ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 54.REST OF ASIA-PACIFIC ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 55.LATIN AMERICA ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 56.MIDDLE EAST ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 57.AFRICA ADAPTOGENS MARKET,2021-2031($MILLION)
  • FIGURE 58. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 59. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 60. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 61.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 62.COMPETITIVE DASHBOARD
  • FIGURE 63.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 64.DABUR INDIA LTD.: NET SALES ,($MILLION)
  • FIGURE 65.EMAMI LIMITED.: NET SALES ,($MILLION)
  • FIGURE 66.KAIRALI AYURVEDIC GROUP.: NET SALES ,($MILLION)
  • FIGURE 67.HIMALAYA WELLNESS.: NET SALES ,($MILLION)
  • FIGURE 68.COLGATE-PALMOLIVE COMPANY.: NET SALES ,($MILLION)
  • FIGURE 69.PROCTER & GAMBLE.: NET SALES ,($MILLION)
  • FIGURE 70.PATANJALI AYURVED LIMITED.: NET SALES ,($MILLION)
  • FIGURE 71.SHAHNAZ AYURVEDA PVT. LTD..: NET SALES ,($MILLION)
  • FIGURE 72.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD.: NET SALES ,($MILLION)
  • FIGURE 73.UNILEVER.: NET SALES ,($MILLION)
  • FIGURE 74.ENOMARK BIOTECH (ENOMARK HEALTHCARE).: NET SALES ,($MILLION)
  • FIGURE 75.RIAAN WELLNESS PVT. LTD..: NET SALES ,($MILLION)
  • FIGURE 76..GIVAUDAN INTERNATIONAL SA (NATUREX S.A.).: NET SALES ,($MILLION)
  • FIGURE 77.PLT HEALTH SOLUTIONS.: NET SALES ,($MILLION)
  • FIGURE 78.INDENA S.P.A.: NET SALES ,($MILLION)
目次
Product Code: A16862

The adaptogens market size was valued at $10,320.2 million in 2021, and is projected to reach $20,328.6 million by 2031, registering a CAGR of 7.3% from 2022 to 2031. Adaptogen is meant to provide the herb that helps the body to regulate its natural metabolism and achieve balance. It helps in lowering mental stress.. Adaptogen plants are found in severe climates, for instance ashwagandha grows in desert. Ingredients such as ashwagandha and the holy basil have been linked to variety of health benefits including ashwagandha's ability to improve sleep. Ginseng, rohdiola, and schisandra are helpful in dealing with acute stress triggers in the body. Ginseng is used to improve the immune system of the body. Among all the adaptogens, ashwagandha has a major market share due to its health benefits.

Adaptogens are available in many forms such as adaptogen teas and the pre mixed powder consisting of adaptogens that can be consumed with food & in the form of capsules. Among all these forms, premix powder of adaptogen has a major market share due to its ability to be consumed with food as well as by mixing in liquid such as water.

The major factors that drive the growth of the adaptogens market are rise in amount of stress among consumers across the globe. In the study of American Institute of Stress, it was founded that about 73% people have stress, which impacts their mental health where as 48% of the people have trouble in sleeping due to stress.

According to the reports of global organization of stress, it was founded that almost 75% of the people experience moderate to high level of stress in the recent years. And to cure such kind of stress, adaptogen are prone to be a novel pharmaceutical solution to it. In addition, rise in demand for adaptogen from beverage industry and healthy food consumers, as adaptogen is available in powder form which help to reduce anxiety and increase the mental stability.Based on application, the adaptogen market is segmented into food & beverages, dietary & sports supplements, cosmetics, animal feed, and pharmaceuticals. Among all the segments food and beverages are holding the largest market share because the usage of adaptogen in meals and in the form of beverages such as tea as a supplement.

Asia-Pacific has a large share for the global adaptogen market. The growth is owing to the fact that the adaptogens are broadly used in ayurveda, which is widely practiced in India and ultimately results in substantial market growth in India. Other Asian countries such as South Korea and China are among the biggest users of adaptogens in traditional medicine. Moreover, rise in the demand from emerging economies and the increase in usage of adaptogens in food & beverage and dietary & sports supplements are going to create new opportunities for the adaptogen market manufacturers in the upcoming future. However rise in the cost of research and development activities acts as a major factor as a restraint and is expected to be a further challenge for the adaptogen market in the upcoming future.

The Adaptogens market is segmented on the basis of source, end use, application, and region. On the basis of source, the market is classified into ashwagandha, ginseng, astragalus, holy basil, rhodiola roseas, schisandra, adaptogenic mushrooms, and others. Depending on end use, it is classified into powder, capsules, teas & beverages, and others. On the basis of application, it is classified into food & beverages, dietary & sports supplements, cosmetics, animal feed, and pharmaceutical. By distribution channel, the market is classified into business to business, and business to consumer. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

According to the market players, the major obstacle attributed to the pandemic was the disruption of the supply chain. Furthermore, all the distribution channels were nearly shut down in the first quarter of the pandemic. However, online channels such as Amazon and Flipkart were delivering products. The key players included in the adaptogens market analysis are Dabur India Ltd, Emami Limited, kairali ayurvedic group, Himalaya Wellness, Colgate-Palmolive Company, Procter & Gamble, Patanjali Ayurved Limited, Shahnaz Ayurveda Pvt. Ltd., Shree Baidyanath Ayurveda Bhawan Pvt. Ltd, Unilever, ENOMARK BIOTECH (ENOMARK HEALTHCARE), Riaan Wellness Pvt. Ltd., Givaudan International SA (NATUREX S.A.), PLT Health Solutions, and INDENA S.P.A.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the adaptogens market analysis from 2021 to 2031 to identify the prevailing adaptogens market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the adaptogens market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global adaptogens market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Source

  • Ashwagandha
  • Ginseng
  • Astragalus
  •  Holy Basils
  •  Rhodiola Roseas
  • Schisandra
  • Adaptogenic mushrooms
  • Others

By End Use

  • Powder
  • Capsules
  • Teas and Beverages
  • Others

By Application

  •  Food and Beverages
  •  Dietary and sports supplements
  • Cosmetics
  •  Animal Feed
  • Pharmaceutical

By Distribution Channel

  • Business to Business
  • Business to Consumer
    • Sales channel
    • Supermarket and hypermarket
    • Specialty store
    • Pharmacies and drug stores
    • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Italy
    • Germany
    • France
    • Spain
    • The Netherlands
    • Switzerland
    • Rest Of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand 
    • Rest Of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
  • Key Market Players
    • Dabur India Ltd
    • Emami Limited
    • kairali ayurvedic group
    • Himalaya Wellness
    • Colgate-Palmolive Company
    • Procter & Gamble
    • Patanjali Ayurved Limited
    • Shahnaz Ayurveda Pvt. Ltd.
    • Shree Baidyanath Ayurveda Bhawan Pvt. Ltd
    • Unilever
    • ENOMARK BIOTECH (ENOMARK HEALTHCARE)
    • Riaan Wellness Pvt. Ltd.
    • .Givaudan International SA (NATUREX S.A.)
    • PLT Health Solutions
    • INDENA S.P.A

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ADAPTOGENS MARKET, BY SOURCE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Ashwagandha
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Ginseng
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Astragalus
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5  Holy Basils
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country
  • 4.6  Rhodiola Roseas
    • 4.6.1 Key market trends, growth factors and opportunities
    • 4.6.2 Market size and forecast, by region
    • 4.6.3 Market analysis by country
  • 4.7 Schisandra
    • 4.7.1 Key market trends, growth factors and opportunities
    • 4.7.2 Market size and forecast, by region
    • 4.7.3 Market analysis by country
  • 4.8 Adaptogenic mushrooms
    • 4.8.1 Key market trends, growth factors and opportunities
    • 4.8.2 Market size and forecast, by region
    • 4.8.3 Market analysis by country
  • 4.9 Others
    • 4.9.1 Key market trends, growth factors and opportunities
    • 4.9.2 Market size and forecast, by region
    • 4.9.3 Market analysis by country

CHAPTER 5: ADAPTOGENS MARKET, BY END USE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Powder
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Capsules
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Teas and Beverages
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Others
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: ADAPTOGENS MARKET, BY APPLICATION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2  Food and Beverages
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3  Dietary and sports supplements
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Cosmetics
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country
  • 6.5  Animal Feed
    • 6.5.1 Key market trends, growth factors and opportunities
    • 6.5.2 Market size and forecast, by region
    • 6.5.3 Market analysis by country
  • 6.6 Pharmaceutical
    • 6.6.1 Key market trends, growth factors and opportunities
    • 6.6.2 Market size and forecast, by region
    • 6.6.3 Market analysis by country

CHAPTER 7: ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 Business to Business
    • 7.2.1 Key market trends, growth factors and opportunities
    • 7.2.2 Market size and forecast, by region
    • 7.2.3 Market analysis by country
  • 7.3 Business to Consumer
    • 7.3.1 Key market trends, growth factors and opportunities
    • 7.3.2 Market size and forecast, by region
    • 7.3.3 Market analysis by country
    • 7.3.4 Business to Consumer Adaptogens Market by Sales channel
      • 7.3.4.1 Supermarket and hypermarket Market size and forecast, by region
      • 7.3.4.2 Specialty store Market size and forecast, by region
      • 7.3.4.3 Pharmacies and drug stores Market size and forecast, by region
      • 7.3.4.4 Others Market size and forecast, by region

CHAPTER 8: ADAPTOGENS MARKET, BY REGION

  • 8.1 Overview
    • 8.1.1 Market size and forecast
  • 8.2 North America
    • 8.2.1 Key trends and opportunities
    • 8.2.2 North America Market size and forecast, by Source
    • 8.2.3 North America Market size and forecast, by End Use
    • 8.2.4 North America Market size and forecast, by Application
    • 8.2.5 North America Market size and forecast, by Distribution Channel
      • 8.2.5.1 North America Business to Consumer Adaptogens Market by Sales channel
    • 8.2.6 North America Market size and forecast, by country
      • 8.2.6.1 U.S.
      • 8.2.6.1.1 Market size and forecast, by Source
      • 8.2.6.1.2 Market size and forecast, by End Use
      • 8.2.6.1.3 Market size and forecast, by Application
      • 8.2.6.1.4 Market size and forecast, by Distribution Channel
      • 8.2.6.2 Canada
      • 8.2.6.2.1 Market size and forecast, by Source
      • 8.2.6.2.2 Market size and forecast, by End Use
      • 8.2.6.2.3 Market size and forecast, by Application
      • 8.2.6.2.4 Market size and forecast, by Distribution Channel
      • 8.2.6.3 Mexico
      • 8.2.6.3.1 Market size and forecast, by Source
      • 8.2.6.3.2 Market size and forecast, by End Use
      • 8.2.6.3.3 Market size and forecast, by Application
      • 8.2.6.3.4 Market size and forecast, by Distribution Channel
  • 8.3 Europe
    • 8.3.1 Key trends and opportunities
    • 8.3.2 Europe Market size and forecast, by Source
    • 8.3.3 Europe Market size and forecast, by End Use
    • 8.3.4 Europe Market size and forecast, by Application
    • 8.3.5 Europe Market size and forecast, by Distribution Channel
      • 8.3.5.1 Europe Business to Consumer Adaptogens Market by Sales channel
    • 8.3.6 Europe Market size and forecast, by country
      • 8.3.6.1 UK
      • 8.3.6.1.1 Market size and forecast, by Source
      • 8.3.6.1.2 Market size and forecast, by End Use
      • 8.3.6.1.3 Market size and forecast, by Application
      • 8.3.6.1.4 Market size and forecast, by Distribution Channel
      • 8.3.6.2 Italy
      • 8.3.6.2.1 Market size and forecast, by Source
      • 8.3.6.2.2 Market size and forecast, by End Use
      • 8.3.6.2.3 Market size and forecast, by Application
      • 8.3.6.2.4 Market size and forecast, by Distribution Channel
      • 8.3.6.3 Germany
      • 8.3.6.3.1 Market size and forecast, by Source
      • 8.3.6.3.2 Market size and forecast, by End Use
      • 8.3.6.3.3 Market size and forecast, by Application
      • 8.3.6.3.4 Market size and forecast, by Distribution Channel
      • 8.3.6.4 France
      • 8.3.6.4.1 Market size and forecast, by Source
      • 8.3.6.4.2 Market size and forecast, by End Use
      • 8.3.6.4.3 Market size and forecast, by Application
      • 8.3.6.4.4 Market size and forecast, by Distribution Channel
      • 8.3.6.5 Spain
      • 8.3.6.5.1 Market size and forecast, by Source
      • 8.3.6.5.2 Market size and forecast, by End Use
      • 8.3.6.5.3 Market size and forecast, by Application
      • 8.3.6.5.4 Market size and forecast, by Distribution Channel
      • 8.3.6.6 The Netherlands
      • 8.3.6.6.1 Market size and forecast, by Source
      • 8.3.6.6.2 Market size and forecast, by End Use
      • 8.3.6.6.3 Market size and forecast, by Application
      • 8.3.6.6.4 Market size and forecast, by Distribution Channel
      • 8.3.6.7 Switzerland
      • 8.3.6.7.1 Market size and forecast, by Source
      • 8.3.6.7.2 Market size and forecast, by End Use
      • 8.3.6.7.3 Market size and forecast, by Application
      • 8.3.6.7.4 Market size and forecast, by Distribution Channel
      • 8.3.6.8 Rest of Europe
      • 8.3.6.8.1 Market size and forecast, by Source
      • 8.3.6.8.2 Market size and forecast, by End Use
      • 8.3.6.8.3 Market size and forecast, by Application
      • 8.3.6.8.4 Market size and forecast, by Distribution Channel
  • 8.4 Asia-Pacific
    • 8.4.1 Key trends and opportunities
    • 8.4.2 Asia-Pacific Market size and forecast, by Source
    • 8.4.3 Asia-Pacific Market size and forecast, by End Use
    • 8.4.4 Asia-Pacific Market size and forecast, by Application
    • 8.4.5 Asia-Pacific Market size and forecast, by Distribution Channel
      • 8.4.5.1 Asia-Pacific Business to Consumer Adaptogens Market by Sales channel
    • 8.4.6 Asia-Pacific Market size and forecast, by country
      • 8.4.6.1 China
      • 8.4.6.1.1 Market size and forecast, by Source
      • 8.4.6.1.2 Market size and forecast, by End Use
      • 8.4.6.1.3 Market size and forecast, by Application
      • 8.4.6.1.4 Market size and forecast, by Distribution Channel
      • 8.4.6.2 Japan
      • 8.4.6.2.1 Market size and forecast, by Source
      • 8.4.6.2.2 Market size and forecast, by End Use
      • 8.4.6.2.3 Market size and forecast, by Application
      • 8.4.6.2.4 Market size and forecast, by Distribution Channel
      • 8.4.6.3 India
      • 8.4.6.3.1 Market size and forecast, by Source
      • 8.4.6.3.2 Market size and forecast, by End Use
      • 8.4.6.3.3 Market size and forecast, by Application
      • 8.4.6.3.4 Market size and forecast, by Distribution Channel
      • 8.4.6.4 South Korea
      • 8.4.6.4.1 Market size and forecast, by Source
      • 8.4.6.4.2 Market size and forecast, by End Use
      • 8.4.6.4.3 Market size and forecast, by Application
      • 8.4.6.4.4 Market size and forecast, by Distribution Channel
      • 8.4.6.5 Australia
      • 8.4.6.5.1 Market size and forecast, by Source
      • 8.4.6.5.2 Market size and forecast, by End Use
      • 8.4.6.5.3 Market size and forecast, by Application
      • 8.4.6.5.4 Market size and forecast, by Distribution Channel
      • 8.4.6.6 Indonesia
      • 8.4.6.6.1 Market size and forecast, by Source
      • 8.4.6.6.2 Market size and forecast, by End Use
      • 8.4.6.6.3 Market size and forecast, by Application
      • 8.4.6.6.4 Market size and forecast, by Distribution Channel
      • 8.4.6.7 Thailand 
      • 8.4.6.7.1 Market size and forecast, by Source
      • 8.4.6.7.2 Market size and forecast, by End Use
      • 8.4.6.7.3 Market size and forecast, by Application
      • 8.4.6.7.4 Market size and forecast, by Distribution Channel
      • 8.4.6.8 Rest of Asia-Pacific
      • 8.4.6.8.1 Market size and forecast, by Source
      • 8.4.6.8.2 Market size and forecast, by End Use
      • 8.4.6.8.3 Market size and forecast, by Application
      • 8.4.6.8.4 Market size and forecast, by Distribution Channel
  • 8.5 LAMEA
    • 8.5.1 Key trends and opportunities
    • 8.5.2 LAMEA Market size and forecast, by Source
    • 8.5.3 LAMEA Market size and forecast, by End Use
    • 8.5.4 LAMEA Market size and forecast, by Application
    • 8.5.5 LAMEA Market size and forecast, by Distribution Channel
      • 8.5.5.1 LAMEA Business to Consumer Adaptogens Market by Sales channel
    • 8.5.6 LAMEA Market size and forecast, by country
      • 8.5.6.1 Latin America
      • 8.5.6.1.1 Market size and forecast, by Source
      • 8.5.6.1.2 Market size and forecast, by End Use
      • 8.5.6.1.3 Market size and forecast, by Application
      • 8.5.6.1.4 Market size and forecast, by Distribution Channel
      • 8.5.6.2 Middle East
      • 8.5.6.2.1 Market size and forecast, by Source
      • 8.5.6.2.2 Market size and forecast, by End Use
      • 8.5.6.2.3 Market size and forecast, by Application
      • 8.5.6.2.4 Market size and forecast, by Distribution Channel
      • 8.5.6.3 Africa
      • 8.5.6.3.1 Market size and forecast, by Source
      • 8.5.6.3.2 Market size and forecast, by End Use
      • 8.5.6.3.3 Market size and forecast, by Application
      • 8.5.6.3.4 Market size and forecast, by Distribution Channel

CHAPTER 9: COMPANY LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Key developments

CHAPTER 10: COMPANY PROFILES

  • 10.1 Dabur India Ltd
    • 10.1.1 Company overview
    • 10.1.2 Company snapshot
    • 10.1.3 Operating business segments
    • 10.1.4 Product portfolio
    • 10.1.5 Business performance
    • 10.1.6 Key strategic moves and developments
  • 10.2 Emami Limited
    • 10.2.1 Company overview
    • 10.2.2 Company snapshot
    • 10.2.3 Operating business segments
    • 10.2.4 Product portfolio
    • 10.2.5 Business performance
    • 10.2.6 Key strategic moves and developments
  • 10.3 kairali ayurvedic group
    • 10.3.1 Company overview
    • 10.3.2 Company snapshot
    • 10.3.3 Operating business segments
    • 10.3.4 Product portfolio
    • 10.3.5 Business performance
    • 10.3.6 Key strategic moves and developments
  • 10.4 Himalaya Wellness
    • 10.4.1 Company overview
    • 10.4.2 Company snapshot
    • 10.4.3 Operating business segments
    • 10.4.4 Product portfolio
    • 10.4.5 Business performance
    • 10.4.6 Key strategic moves and developments
  • 10.5 Colgate-Palmolive Company
    • 10.5.1 Company overview
    • 10.5.2 Company snapshot
    • 10.5.3 Operating business segments
    • 10.5.4 Product portfolio
    • 10.5.5 Business performance
    • 10.5.6 Key strategic moves and developments
  • 10.6 Procter & Gamble
    • 10.6.1 Company overview
    • 10.6.2 Company snapshot
    • 10.6.3 Operating business segments
    • 10.6.4 Product portfolio
    • 10.6.5 Business performance
    • 10.6.6 Key strategic moves and developments
  • 10.7 Patanjali Ayurved Limited
    • 10.7.1 Company overview
    • 10.7.2 Company snapshot
    • 10.7.3 Operating business segments
    • 10.7.4 Product portfolio
    • 10.7.5 Business performance
    • 10.7.6 Key strategic moves and developments
  • 10.8 Shahnaz Ayurveda Pvt. Ltd.
    • 10.8.1 Company overview
    • 10.8.2 Company snapshot
    • 10.8.3 Operating business segments
    • 10.8.4 Product portfolio
    • 10.8.5 Business performance
    • 10.8.6 Key strategic moves and developments
  • 10.9 Shree Baidyanath Ayurveda Bhawan Pvt. Ltd
    • 10.9.1 Company overview
    • 10.9.2 Company snapshot
    • 10.9.3 Operating business segments
    • 10.9.4 Product portfolio
    • 10.9.5 Business performance
    • 10.9.6 Key strategic moves and developments
  • 10.10 Unilever
    • 10.10.1 Company overview
    • 10.10.2 Company snapshot
    • 10.10.3 Operating business segments
    • 10.10.4 Product portfolio
    • 10.10.5 Business performance
    • 10.10.6 Key strategic moves and developments
  • 10.11 ENOMARK BIOTECH (ENOMARK HEALTHCARE)
    • 10.11.1 Company overview
    • 10.11.2 Company snapshot
    • 10.11.3 Operating business segments
    • 10.11.4 Product portfolio
    • 10.11.5 Business performance
    • 10.11.6 Key strategic moves and developments
  • 10.12 Riaan Wellness Pvt. Ltd.
    • 10.12.1 Company overview
    • 10.12.2 Company snapshot
    • 10.12.3 Operating business segments
    • 10.12.4 Product portfolio
    • 10.12.5 Business performance
    • 10.12.6 Key strategic moves and developments
  • 10.13 .Givaudan International SA (NATUREX S.A.)
    • 10.13.1 Company overview
    • 10.13.2 Company snapshot
    • 10.13.3 Operating business segments
    • 10.13.4 Product portfolio
    • 10.13.5 Business performance
    • 10.13.6 Key strategic moves and developments
  • 10.14 PLT Health Solutions
    • 10.14.1 Company overview
    • 10.14.2 Company snapshot
    • 10.14.3 Operating business segments
    • 10.14.4 Product portfolio
    • 10.14.5 Business performance
    • 10.14.6 Key strategic moves and developments
  • 10.15 INDENA S.P.A
    • 10.15.1 Company overview
    • 10.15.2 Company snapshot
    • 10.15.3 Operating business segments
    • 10.15.4 Product portfolio
    • 10.15.5 Business performance
    • 10.15.6 Key strategic moves and developments